Recurrent membranous nephropathy with a possible alteration in the etiology: a case report
暂无分享,去创建一个
Ayumi Matsumoto | Y. Isaka | T. Oki | Kazunori Inoue | T. Kaneko | I. Matsui | T. Hanai | K. Kojima | Seiichi Yasuda | Karin Shimada | H. Mizuno | Yusuke Katsuma | Keiji Mano
[1] Ayumi Matsumoto,et al. Single cell RNA sequencing uncovers cellular developmental sequences and novel potential intercellular communications in embryonic kidney , 2021, Scientific Reports.
[2] Y. Sakata,et al. Maxacalcitol (22-Oxacalcitriol (OCT)) Retards Progression of Left Ventricular Hypertrophy with Renal Dysfunction Through Inhibition of Calcineurin-NFAT Activity , 2020, Cardiovascular Drugs and Therapy.
[3] S. Ishizuka,et al. Lithocholic acid increases intestinal phosphate and calcium absorption in a vitamin D receptor dependent but transcellular pathway independent manner. , 2020, Kidney international.
[4] Ayumi Matsumoto,et al. VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] Ayumi Matsumoto,et al. Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23. , 2018, Kidney international.
[6] S. Takashima,et al. Protein carbamylation exacerbates vascular calcification. , 2018, Kidney international.
[7] D. Salant,et al. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.
[8] F. Cosio,et al. Temporal IgG Subtype Changes in Recurrent Idiopathic Membranous Nephropathy , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] P. Stahl,et al. A Mechanism for Cancer-Associated Membranous Nephropathy. , 2016, The New England journal of medicine.
[10] L. Beck,et al. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity , 2016, Modern Pathology.
[11] H. Rakugi,et al. Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype. , 2015, Kidney international.
[12] G. Remuzzi,et al. Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy , 2015, PloS one.
[13] J. Klein,et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. , 2015, The New England journal of medicine.
[14] N. Fujii,et al. Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats. , 2014, Journal of the American Society of Nephrology : JASN.
[15] V. Tesar,et al. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] N. Fujii,et al. Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats. , 2013, American journal of physiology. Renal physiology.
[17] H. Debiec,et al. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. , 2011, The New England journal of medicine.
[18] 克治 桑門. 海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .
[19] David M. Beck,et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.
[20] Peter Carmeliet,et al. VEGF as a Key Mediator of Angiogenesis in Cancer , 2005, Oncology.